PRME - Prime Medicine, Inc.
NEXT EARNINGS:
Feb 27, 2026
(in 2 days)
EPS Est: $-0.25
|
Rev Est: $2.1M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.25
DETAILS
HIGH:
$23.00
LOW:
$12.00
MEDIAN:
$17.00
CONSENSUS:
$17.25
UPSIDE:
350.39%
Market Cap:
691.36M
Volume:
3,373,783
Avg Volume:
3,184,465
52 Week Range:
1.11-6.94
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.72
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
214
IPO Date:
2022-10-20
EPS (TTM):
-1.65
P/E Ratio:
-1.77
Revenue (TTM):
2.98M
Total Assets:
297.51M
Total Debt:
40.79M
Cash & Equiv:
182.48M
Rev Growth (5Y):
-13.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-78.0%
Debt/Equity:
0.27
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-07 | $-0.32 | $-0.28 | -14.3% | $1.2M | $2.1M | -40.3% |
| 2025-08-07 | $-0.41 | $-0.36 | -13.9% | $1.1M | $2.8M | -60.2% |
| 2025-05-08 | $-0.40 | $-0.32 | -25.0% | $1.5M | $2.3M | -37.7% |
| 2025-02-28 | $-0.31 | $-0.37 | +16.2% | $2.2M | $6.8M | -67.8% |
| 2024-11-12 | $-0.44 | $-0.43 | -2.3% | $209000 | $7.1M | -97.1% |
| 2024-08-08 | $-0.46 | $-0.40 | -15.0% | $37.8M | $1.6M | +2217.4% |
| 2024-05-10 | $-0.44 | $-0.45 | +2.2% | $591000 | $1.9M | -69.3% |
| 2024-03-01 | $-0.56 | $-0.48 | -16.7% | — | $5.7M | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 2.98M | 0 | 0 | 0 | 5.21M | 0 |
| Net Income | (195.88M) | (198.13M) | (121.82M) | (165.37M) | (3.41M) | (2.53M) |
| EPS | -1.65 | -2.18 | -1.46 | -1.92 | -0.05 | -0.03 |
| Total Assets | 297.51M | 193.85M | 360.31M | 301.86M | 54.78M | 8.70M |
| Total Debt | 40.79M | 13.63M | 28.75M | 10.41M | 0 | 0 |
| Cash & Equivalents | 182.48M | 41.57M | 187.62M | 185.42M | 36.98M | 8.65M |
| Operating Cash Flow | (122.86M) | (165.41M) | (131.83M) | (34.08M) | (5.54M) | (1.33M) |
| Free Cash Flow | (130.16M) | (174.14M) | (147.92M) | (38.23M) | (6.18M) | (1.33M) |
| FCF per Share | -1.10 | -1.91 | -1.52 | -0.40 | -0.06 | -0.01 |
| Book Value | 153.15M | 133.07M | 316.27M | 239.56M | 33.47M | 1.39M |
| Cash & ST Investments | 190.44M | 121.67M | 293.92M | 269.62M | 53.33M | 8.65M |
| ROC Equity | -1.28 | -1.49 | -0.39 | -0.69 | -0.10 | -1.82 |